Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Essential fatty acids
DIETARY_SUPPLEMENT
3 trials
Sponsors
National Center for Complementary and Integrative Health (NCCIH)
, Universität des Saarlandes
, Medical University of Lodz
Conditions
Adult Attention Deficit Hyperactivity Disorder
Multiple Sclerosis
Schizophrenia
Phase 1
Natural Antioxidants in the Treatment of Multiple Sclerosis
Completed
NCT00010842
National Center for Complementary and Integrative Health (NCCIH)
Multiple Sclerosis
Start: 1999-09-30
End: 2004-12-31
Updated: 2006-08-18
Phase 3
Essential Fatty Acids in Adult ADHD
Completed
NCT01798381
Universität des Saarlandes
Adult Attention Deficit Hyperactivity Disorder
Start: 2012-12-31
End: 2015-12-31
Updated: 2020-10-29
Phase 4
Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia
NCT02210962
Medical University of Lodz
Schizophrenia
Start: 2011-09-30
End: 2015-02-28
Target: 80
Updated: 2015-02-18
Related Papers
Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods
BMC Psychiatry
2015-05-01
45 citations